European Regulatory Update: UK and EU Ingredient Management
The UK and EU have made robust regulatory changes due to recently trending ingredient concerns. Updated guidances for lilial, DHA and cyclic silicones are outlined here, along with other regional updates.
Jun 1st, 2022
FDA Approves First Systemic Alopecia Areata Treatment
US Senate Bill to Strengthen Cosmetic Oversight Advances
The Estée Lauder Companies' Virtual Try-on Targeted by Lawsuit
Plaintiffs allege that The Estée Lauder Companies, Inc. engaged in "undisclosed collection of consumers’ biometric facial scans in Illinois."
May 26th, 2022
Senate Considers FDA Fee Reauthorization Approach to Cosmetic Oversight
Senate members will present a draft legislation to reform the U.S. Food and Drug Administration's (FDA's) oversight of cosmetics, supplements and some lab-based tests based on a fee reauthorization approach, STAT reports.
May 16th, 2022
Asia-Pacific Regulatory Update: GMPs, Safety, Ingredient Restrictions, Claims and More
As the first quarter of 2022 came to a close, several regulatory changes were announced in the Asia-Pacific region. Following is an overview, which includes ingredient restrictions, claims guidelines, adverse reactions and more.
May 1st, 2022
Kalibiome: Pure Postbiotics for Skin, Hair, Oral and Intimate Microbiome.
Innovation based on a platform of reproducible and purified postbiotics, obtained through a patented bio-fermentation enabling to design biotech actives specific for sensitive skin, anti-age, hair care and oral applications.
Jun 21st, 2022
FDA Flags 12 Companies for Illicit Hydroquinone-containing Skin Brighteners
The products contain the active drug hydroquinone, rendering them unapproved over-the-counter (OTC) drugs rather than cosmetics.
Apr 19th, 2022
China Drafts 2022 Safety and Technical Standard for Cosmetics
This draft will supersede the 2015 edition, which includes the overarching technical standards for cosmetics safety supervision and testing in China. Public comments will be accepted through April 30, 2022.
Apr 11th, 2022
European Regulatory Update: EGD, Packaging and Green Claims
In parallel with the Green Deal, the EU will outline sustainability measures and crackdown on packaging waste, plastics and green claims. This column provides an overview, along with a brief look at microbiome claims.
Mar 1st, 2022
Health Canada Recalls Bioderma Micellar Water, Brut Deo, Equate Oral Rinse
In recent months, Health Canada has recalled Bioderma Sensibio H2O Micellar Water and Equate Dry Mouth Oral Rinse due to microbial contamination. Also, Unilever's Brut Classic Aerosol Spray deodorant was recalled for potential benzene content.
Mar 8th, 2022
FDA Flags Color Additive, SPF and Contaminant Offenses, Urges 'Recall Readiness'
In recent months, the U.S. Food and Drug Administration (FDA) reported six voluntary recalls for an impermissible color additive, mislabeled SPF and several contaminants. It also urged companies to be "recall ready" and provided final guidance to do so.
Mar 3rd, 2022
Consumers Alarmed Over Lilial Ban and Social Media Misdirection with Olaplex
Lilial is now classified as a carcinogenic, mutagenic or reprotoxic (CMR) Category 1B substance and is banned in the EU. In relation, Glamour recently shamed TikTok videos for misleading consumers that Olaplex No. 3 contains it and is also banned.
Mar 2nd, 2022
[updated] Hemp Act Proposes Higher THC Test Limits but Could Impact CBDs
The Hemp Advancement Act of 2022 seeks to eliminate unworkable testing requirements and set reasonable THC thresholds, according to
But could it impact other cannabinoids?
Feb 14th, 2022